Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR0B1 | P51843 | 1/20 | 1.00 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.79 |
| ▸ | CCR5 | P51681 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.46 |
| ▸ | SLC2A2 | P11168 | 1/20 | 0.46 |
| ▸ | SLC2A3 | P11169 | 1/20 | 0.46 |
| ▸ | SLC2A4 | P14672 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | SLC2A9 | Q9NRM0 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.46 |
| ▸ | ABCB1 | P08183 | 8/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cytochalasin D SCHEMBL16502284 | 1.00 | NR0B1 (1.00) | NR0B1ADORA3CCR5MEN1KMT2A | |
| Cytochalasin D SCHEMBL33529 | 1.00 | NR0B1 (1.00) | NR0B1ADORA3CCR5MEN1KMT2A | |
| Cytochalasin D SCHEMBL31734099 | 1.00 | NR0B1 (1.00) | NR0B1ADORA3CCR5MEN1KMT2A | |
| Cytochalasin D SCHEMBL29375699 | 1.00 | NR0B1 (1.00) | NR0B1ADORA3CCR5MEN1KMT2A | |
| Cytochalasin D SCHEMBL25847004 | 1.00 | NR0B1 (1.00) | NR0B1ADORA3CCR5MEN1KMT2A | |
| Cytochalasin D SCHEMBL12648577 | 1.00 | NR0B1 (1.00) | NR0B1ADORA3CCR5MEN1KMT2A | |
| SCHEMBL29745878 | 0.93 | NR0B1 (0.86) | NR0B1ADORA3CCR5MEN1KMT2A | |
| Zygosporin D SCHEMBL34014 | 0.89 | NR0B1 (0.80) | NR0B1ADORA3CCR5MEN1KMT2A | |
| SCHEMBL22621306 | 0.88 | NR0B1 (0.79) | NR0B1ADORA3CCR5MEN1KMT2A | |
| SCHEMBL33708 | 0.88 | ADORA3 (1.00) | NR0B1ADORA3CCR5MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5303 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116333993-B | Construction method of aneuploid ovarian cancer cell model | 复旦大学附属妇产科医院 | 2026-05-19 | — | — | CN | claimed |
| EP-4735884-A1 | METHOD OF SCREENING COMPOUNDS FOR ASSESSING ENDOCYTIC ACTIVITY IN THE CONTEXT OF NEURODEGENERATIVE DISORDERS | National Centre For Cell Science (IN) | 2026-05-06 | — | — | EP | claimed |
| EP-3411059-B1 | METHOD TO ENHANCE THE EFFICIENCY OF SYSTEMIC AAV GENE DELIVERY TO THE CENTRAL NERVOUS SYSTEM | UNIV MASSACHUSETTS (US) | 2026-05-06 | — | — | EP | claimed |
| EP-4058037-B1 | FIBROBLAST-BASED THERAPY FOR TREATMENT AND PREVENTION OF STROKE | SPINALCYTE LLC (US) | 2026-01-28 | — | — | EP | claimed |
| EP-3350313-B1 | DERIVATION OF LIVER ORGANOIDS FROM HUMAN PLURIPOTENT STEM CELLS | AGENCY FOR SCIENCE TECH AND RESEARCH ASTARSTAR (SG) | 2025-11-26 | — | — | EP | claimed |
| EP-4642933-A1 | COMPOSITIONS, KITS AND METHODS FOR DETERMINING PERSONALIZED TREATMENT REGIMEN | Ramot at Tel-Aviv University Ltd. (IL) | 2025-11-05 | — | — | EP | claimed |
| US-12399187-B2 | Controlled blood delivery to mixing chamber of a blood testing cartridge | CA CASYSO GMBH (CH) | 2025-08-26 | — | — | US | claimed |
| US-20250223564-A1 | HYPOIMMUNE BETA CELLS DIFFERENTIATED FROM PLURIPOTENT STEM CELLS AND RELATED USES AND METHODS | SANA BIOTECHNOLOGY, INC. | 2025-07-10 | — | — | US | claimed |
| WO-2025109524-A1 | ASSAYS AND METHODS FOR ASSESSING VACCINE PREPARATIONS | AC IMMUNE SA (CH) | 2025-05-30 | — | — | WO | claimed |
| EP-3734274-B1 | SYSTEM FOR MEASURING VISCOELASTIC PROPERTIES OF BLOOD | C A CASYSO GMBH (CH) | 2025-04-23 | — | — | EP | claimed |
| EP-0684762-A1 | PRESERVATION OF BLOOD PLATELETS | BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 1995-12-06 | — | — | EP | claimed |
| EP-0681475-A1 | THERAPEUTIC INHIBITORS OF VASCULAR SMOOTH MUSCLE CELLS | NEORX CORPORATION (US) | 1995-11-15 | — | — | EP | claimed |
| US-5358844-A | Treating platelets with agent for inhibiting actin filament severing and another for inhibiting actin addition reactions, then low temperature storage preserves hemostatic activity | BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 1994-10-25 | — | — | US | claimed |
| EP-0616530-A1 | USE OF CYTOCHALASINS FOR INHIBITING VIRAL REPLICATION | Usher, Thomas Clemens (BS) | 1994-09-28 | — | — | EP | claimed |
| WO-1994018829-A1 | PRESERVATION OF BLOOD PLATELETS | BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 1994-09-01 | — | — | WO | claimed |
| WO-1994016706-A1 | THERAPEUTIC INHIBITORS OF VASCULAR SMOOTH MUSCLE CELLS | NEORX CORPORATION (US) | 1994-08-04 | — | — | WO | claimed |
| WO-1993011763-A1 | USE OF CYTOCHALASINS FOR INHIBITING VIRAL REPLICATION | USHER THOMAS C (BS) | 1993-06-24 | — | — | WO | claimed |
| EP-0429585-A4 | CYTOCHALASIN COMPOSITIONS AND THERAPEUTIC METHODS | — | 1992-03-25 | — | — | EP | claimed |
| EP-0429585-A1 | CYTOCHALASIN COMPOSITIONS AND THERAPEUTIC METHODS | SYRACUSE UNIVERSITY (US) | 1991-06-05 | — | — | EP | claimed |
| WO-1990013293-A1 | CYTOCHALASIN COMPOSITIONS AND THERAPEUTIC METHODS | SYRACUSE UNIVERSITY (US) | 1990-11-15 | — | — | WO | claimed |